Genetic analyses of a large cohort of infertile patients with globozoospermia, DPY19L2 still the main actor, GGN confirmed as a guest player.


Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 06 08 2020
accepted: 15 10 2020
pubmed: 28 10 2020
medline: 18 2 2021
entrez: 27 10 2020
Statut: ppublish

Résumé

Globozoospermia is a rare phenotype of primary male infertility inducing the production of round-headed spermatozoa without acrosome. Anomalies of DPY19L2 account for 50-70% of all cases and the entire deletion of the gene is by far the most frequent defect identified. Here, we present a large cohort of 69 patients with 20-100% of globozoospermia. Genetic analyses including multiplex ligation-dependent probe amplification, Sanger sequencing and whole-exome sequencing identified 25 subjects with a homozygous DPY19L2 deletion (36%) and 14 carrying other DPY19L2 defects (20%). Overall, 11 deleterious single-nucleotide variants were identified including eight novel and three already published mutations. Patients with a higher rate of round-headed spermatozoa were more often diagnosed and had a higher proportion of loss of function anomalies, highlighting a good genotype phenotype correlation. No gene defects were identified in patients carrying < 50% of globozoospermia while diagnosis efficiency rose to 77% for patients with > 50% of globozoospermia. In addition, results from whole-exome sequencing were scrutinized for 23 patients with a DPY19L2 negative diagnosis, searching for deleterious variants in the nine other genes described to be associated with globozoospermia in human (C2CD6, C7orf61, CCDC62, CCIN, DNAH17, GGN, PICK1, SPATA16, and ZPBP1). Only one homozygous novel truncating variant was identified in the GGN gene in one patient, confirming the association of GGN with globozoospermia. In view of these results, we propose a novel diagnostic strategy focusing on patients with at least 50% of globozoospermia and based on a classical qualitative PCR to detect DPY19L2 homozygous deletions. In the absence of the latter, we recommend to perform whole-exome sequencing to search for defects in DPY19L2 as well as in the other previously described candidate genes.

Identifiants

pubmed: 33108537
doi: 10.1007/s00439-020-02229-0
pii: 10.1007/s00439-020-02229-0
doi:

Substances chimiques

DPY19L2 protein, human 0
Membrane Proteins 0
Testicular Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-57

Subventions

Organisme : Agence Nationale de la Recherche
ID : FLAGEL_OME

Références

Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. https://doi.org/10.1038/nmeth0410-248
doi: 10.1038/nmeth0410-248 pubmed: 2855889 pmcid: 2855889
Alimohammadi F, Ebrahimi Nasab M, Rafaee A et al (2020) Deletion of dpy-19 like 2 (DPY19L2) gene is associated with total but not partial globozoospermia. Reprod Fertil Dev. https://doi.org/10.1071/RD19025
doi: 10.1071/RD19025 pubmed: 32389181
Anton-Lamprecht I, Kotzur B, Schopf E (1976) Round-headed human spermatozoa. Fertil Steril 27:685–693. https://doi.org/10.1016/s0015-0282(16)41900-x
doi: 10.1016/s0015-0282(16)41900-x pubmed: 1278463
Buettner FFR, Ashikov A, Tiemann B et al (2013) C. elegans DPY-19 is a C-mannosyltransferase glycosylating thrombospondin repeats. Mol Cell 50:295–302. https://doi.org/10.1016/j.molcel.2013.03.003
doi: 10.1016/j.molcel.2013.03.003 pubmed: 23562325
Chemes HE (2018) Phenotypic varieties of sperm pathology: genetic abnormalities or environmental influences can result in different patterns of abnormal spermatozoa. Anim Reprod Sci 194:41–56. https://doi.org/10.1016/j.anireprosci.2018.04.074
doi: 10.1016/j.anireprosci.2018.04.074 pubmed: 29753534
Chen S, Zhou Y, Chen Y, Gu J (2018) Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884–i890. https://doi.org/10.1093/bioinformatics/bty560
doi: 10.1093/bioinformatics/bty560 pubmed: 30423086 pmcid: 6129281
Chianese C, Fino MG, Riera Escamilla A et al (2015) Comprehensive investigation in patients affected by sperm macrocephaly and globozoospermia. Andrology 3:203–212. https://doi.org/10.1111/andr.12016
doi: 10.1111/andr.12016 pubmed: 25755131
Cooper TG, Noonan E, von Eckardstein S et al (2010) World Health Organization reference values for human semen characteristics*‡. Hum Reprod Update 16:231–245. https://doi.org/10.1093/humupd/dmp048
doi: 10.1093/humupd/dmp048 pubmed: 19934213
Coutton C, Vieville G, Satre V et al (2012a) Multiplex ligation-dependent probe amplification (MLPA) et sondes « à façon » entièrement synthétiques. Guide pratique, recommandations et expérience au CHU de Grenoble. IRBM 33:227–235. https://doi.org/10.1016/j.irbm.2012.04.004
doi: 10.1016/j.irbm.2012.04.004
Coutton C, Zouari R, Abada F et al (2012b) MLPA and sequence analysis of DPY19L2 reveals point mutations causing globozoospermia. Hum Reprod 27:2549–2558. https://doi.org/10.1093/humrep/des160
doi: 10.1093/humrep/des160 pubmed: 22627659
Coutton C, Abada F, Karaouzene T et al (2013) Fine characterisation of a recombination hotspot at the DPY19L2 locus and resolution of the paradoxical excess of duplications over deletions in the general population. PLoS Genet 9:e1003363. https://doi.org/10.1371/journal.pgen.1003363
doi: 10.1371/journal.pgen.1003363 pubmed: 23555282 pmcid: 3605140
Coutton C, Escoffier J, Martinez G et al (2015) Teratozoospermia: spotlight on the main genetic actors in the human. Hum Reprod Update 21:455–485. https://doi.org/10.1093/humupd/dmv020
doi: 10.1093/humupd/dmv020 pubmed: 25888788
Dam AHDM, Koscinski I, Kremer JAM et al (2007) Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet 81:813–820. https://doi.org/10.1086/521314
doi: 10.1086/521314 pubmed: 17847006 pmcid: 2227931
Dam AH, Ramos L, Dijkman HB et al (2011) Morphology of partial globozoospermia. J Androl 32:199–206. https://doi.org/10.2164/jandrol.109.009530
doi: 10.2164/jandrol.109.009530 pubmed: 20864651
Datta J, Palmer MJ, Tanton C et al (2016) Prevalence of infertility and help seeking among 15 000 women and men. Hum Reprod 31:2108–2118. https://doi.org/10.1093/humrep/dew123
doi: 10.1093/humrep/dew123 pubmed: 27365525 pmcid: 4991655
den Dunnen JT, Antonarakis SE (2000) Mutation nomenclaturess extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7–12. https://doi.org/10.1002/(SICI)1098-1004(200001)15:1%3c7::AID-HUMU4%3e3.0.CO;2-N
doi: 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N
Desmet F-O, Hamroun D, Lalande M et al (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e67. https://doi.org/10.1093/nar/gkp215
doi: 10.1093/nar/gkp215 pubmed: 19339519 pmcid: 2685110
Elinati E, Kuentz P, Redin C et al (2012) Globozoospermia is mainly due to DPY19L2 deletion via non-allelic homologous recombination involving two recombination hotspots. Hum Mol Genet 21:3695–3702. https://doi.org/10.1093/hmg/dds200
doi: 10.1093/hmg/dds200 pubmed: 22653751
ElInati E, Fossard C, Okutman O et al (2016) A new mutation identified in SPATA16 in two globozoospermic patients. J Assist Reprod Genet 33:815–820. https://doi.org/10.1007/s10815-016-0715-3
doi: 10.1007/s10815-016-0715-3 pubmed: 27086357 pmcid: 4889487
Ghédir H, Ibala-Romdhane S, Okutman O et al (2016) Identification of a new DPY19L2 mutation and a better definition of DPY19L2 deletion breakpoints leading to globozoospermia. Mol Hum Reprod 22:35–45. https://doi.org/10.1093/molehr/gav061
doi: 10.1093/molehr/gav061 pubmed: 26516168
Ghédir H, Braham A, Viville S et al (2019) Comparison of sperm morphology and nuclear sperm quality in SPATA16- and DPY19L2-mutated globozoospermic patients. Andrologia 51:e13277. https://doi.org/10.1111/and.13277
doi: 10.1111/and.13277 pubmed: 30912172
Guan R, Wen X-Y, Wu J et al (2012) Knockdown of ZNF403 inhibits cell proliferation and induces G2/M arrest by modulating cell-cycle mediators. Mol Cell Biochem 365:211–222. https://doi.org/10.1007/s11010-012-1262-6
doi: 10.1007/s11010-012-1262-6 pubmed: 22350815
Han T, Wang L, Tang W et al (2020) GGNBP1 ensures proper spermiogenesis in response to stress in mice. Biochem Biophys Res Commun 525:706–713. https://doi.org/10.1016/j.bbrc.2020.02.118
doi: 10.1016/j.bbrc.2020.02.118 pubmed: 32139124
Harbuz R, Zouari R, Pierre V et al (2011) A recurrent deletion of DPY19L2 causes infertility in man by blocking sperm head elongation and acrosome formation. Am J Hum Genet 88:351–361. https://doi.org/10.1016/j.ajhg.2011.02.007
doi: 10.1016/j.ajhg.2011.02.007 pubmed: 21397064 pmcid: 3059422
Jamsai D, Bianco DM, Smith SJ et al (2008) Characterization of gametogenetin 1 (GGN1) and its potential role in male fertility through the interaction with the ion channel regulator, cysteine-rich secretory protein 2 (CRISP2) in the sperm tail. Reproduction 135:751–759. https://doi.org/10.1530/REP-07-0485
doi: 10.1530/REP-07-0485 pubmed: 18502891
Jamsai D, O’Connor AE, DeBoer KD et al (2013) Loss of GGN leads to pre-implantation embryonic lethality and compromised male meiotic DNA double strand break repair in the mouse. PLoS ONE 8:e56955. https://doi.org/10.1371/journal.pone.0056955
doi: 10.1371/journal.pone.0056955 pubmed: 23451117 pmcid: 3579931
Kim S, Scheffler K, Halpern AL et al (2018) Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods 15:591–594. https://doi.org/10.1038/s41592-018-0051-x
doi: 10.1038/s41592-018-0051-x pubmed: 30013048
Kopanos C, Tsiolkas V, Kouris A et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35:1978–1980. https://doi.org/10.1093/bioinformatics/bty897
doi: 10.1093/bioinformatics/bty897 pubmed: 30376034
Koscinski I, ElInati E, Fossard C et al (2011) DPY19L2 deletion as a major cause of globozoospermia. Am J Hum Genet 88:344–350. https://doi.org/10.1016/j.ajhg.2011.01.018
doi: 10.1016/j.ajhg.2011.01.018 pubmed: 21397063 pmcid: 3059416
Li H (2013) Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:13033997 [q-bio]
Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25:2078–2079. https://doi.org/10.1093/bioinformatics/btp352
doi: 10.1093/bioinformatics/btp352 pubmed: 19505943 pmcid: 19505943
Liu G, Shi Q-W, Lu G-X (2010) A newly discovered mutation in PICK1 in a human with globozoospermia. Asian J Androl 12:556–560. https://doi.org/10.1038/aja.2010.47
doi: 10.1038/aja.2010.47 pubmed: 20562896 pmcid: 3739375
Lu B, Bishop CE (2003) Mouse GGN1 and GGN3, two germ cell-specific proteins from the single gene Ggn, interact with mouse POG and play a role in spermatogenesis. J Biol Chem 278:16289–16296. https://doi.org/10.1074/jbc.M211023200
doi: 10.1074/jbc.M211023200 pubmed: 12574169
Mascarenhas MN, Flaxman SR, Boerma T et al (2012) National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLOS Med 9:e1001356. https://doi.org/10.1371/journal.pmed.1001356
doi: 10.1371/journal.pmed.1001356 pubmed: 23271957 pmcid: 3525527
McLaren W, Gil L, Hunt SE et al (2016) The ensembl variant effect predictor. Genome Biol 17:122. https://doi.org/10.1186/s13059-016-0974-4
doi: 10.1186/s13059-016-0974-4 pubmed: 27268795 pmcid: 4893825
Modarres P, Tanhaei S, Tavalaee M et al (2016) Assessment of DPY19L2 deletion in familial and non-familial individuals with globozoospermia and DPY19L2 genotyping. Int J Fertil Steril 10:196–207
pubmed: 27441053 pmcid: 4948072
Modarres P, Tavalaee M, Ghaedi K, Nasr-Esfahani MH (2018) An overview of the globozoospermia as a multigenic identified syndrome. IJFS. https://doi.org/10.22074/ijfs.2019.5561
doi: 10.22074/ijfs.2019.5561 pubmed: 30291685
Oud MS, Okutman Ö, Hendricks LAJ et al (2020) Exome sequencing reveals novel causes as well as new candidate genes for human globozoospermia. Hum Reprod 35:240–252. https://doi.org/10.1093/humrep/dez246
doi: 10.1093/humrep/dez246 pubmed: 31985809 pmcid: 6993856
Pierre V, Martinez G, Coutton C et al (2012) Absence of Dpy19l2, a new inner nuclear membrane protein, causes globozoospermia in mice by preventing the anchoring of the acrosome to the nucleus. Development 139:2955–2965. https://doi.org/10.1242/dev.077982
doi: 10.1242/dev.077982 pubmed: 22764053
Ray PF, Toure A, Metzler-Guillemain C et al (2017) Genetic abnormalities leading to qualitative defects of sperm morphology or function: genetic abnormalities leading to qualitative sperm defects. Clin Genet 91:217–232. https://doi.org/10.1111/cge.12905
doi: 10.1111/cge.12905 pubmed: 27779748
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–423. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
Shang Y-L, Zhu F-X, Yan J et al (2019) Novel DPY19L2 variants in globozoospermic patients and the overcoming this male infertility. Asian J Androl 21:183–189. https://doi.org/10.4103/aja.aja_79_18
doi: 10.4103/aja.aja_79_18 pubmed: 30333325
Singh G (1992) Ultrastructural features of round-headed human spermatozoa. Int J Fertil 37:99–102
pubmed: 1349598
Tokuhiro K, Isotani A, Yokota S et al (2009) OAZ-t/OAZ3 is essential for rigid connection of sperm tails to heads in mouse. PLoS Genet 5:e1000712. https://doi.org/10.1371/journal.pgen.1000712
doi: 10.1371/journal.pgen.1000712 pubmed: 19893612 pmcid: 2763286
Touré A, Martinez G, Kherraf Z-E et al (2020) The genetic architecture of morphological abnormalities of the sperm tail. Hum Genet. https://doi.org/10.1007/s00439-020-02113-x
doi: 10.1007/s00439-020-02113-x pubmed: 31950240
Yatsenko AN, O’Neil DS, Roy A et al (2012) Association of mutations in the zona pellucida binding protein 1 (ZPBP1) gene with abnormal sperm head morphology in infertile men. Mol Hum Reprod 18:14–21. https://doi.org/10.1093/molehr/gar057
doi: 10.1093/molehr/gar057 pubmed: 21911476
Zhang J, Wang Y, Zhou Y et al (2005) Yeast two-hybrid screens imply that GGNBP1, GGNBP2 and OAZ3 are potential interaction partners of testicular germ cell-specific protein GGN1. FEBS Lett 579:559–566. https://doi.org/10.1016/j.febslet.2004.10.112
doi: 10.1016/j.febslet.2004.10.112 pubmed: 15642376
Zhou Y, Zhao Q, Bishop CE et al (2005) Identification and characterization of a novel testicular germ cell-specific geneGgnbp1. Mol Reprod Dev 70:301–307. https://doi.org/10.1002/mrd.20214
doi: 10.1002/mrd.20214 pubmed: 15625700
Zhu F, Gong F, Lin G, Lu G (2013) DPY19L2 gene mutations are a major cause of globozoospermia: identification of three novel point mutations. Mol Hum Reprod 19:395–404. https://doi.org/10.1093/molehr/gat018
doi: 10.1093/molehr/gat018 pubmed: 23512994

Auteurs

Tristan Celse (T)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.

Caroline Cazin (C)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.

Flore Mietton (F)

CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.

Guillaume Martinez (G)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM de Génétique Chromosomique, 38000, Grenoble, France.

Delphine Martinez (D)

CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.

Nicolas Thierry-Mieg (N)

Université Grenoble Alpes, CNRS, TIMC-IMAG, 38000, Grenoble, France.

Amandine Septier (A)

Université Grenoble Alpes, CNRS, TIMC-IMAG, 38000, Grenoble, France.

Catherine Guillemain (C)

Pôle Femmes-Parents-Enfants, Centre Clinico-Biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Assistance-Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
Aix Marseille University, INSERM, MMG, UMR_S 1251, Marseille, France.

Julie Beurois (J)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.

Antoine Clergeau (A)

Diabetes Care Unit, University Hospital of Caen, Caen, France.

Selima Fourati Ben Mustapha (SFB)

Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.

Mahmoud Kharouf (M)

Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.

Abdelali Zoghmar (A)

Reproduction Sciences and Surgery Clinique, Ibn Rochd, Constantine, Algeria.

Ahmed Chargui (A)

Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire (CHU) Cochin, Service d'Histologie-Embryologie-Biologie de la Reproduction, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Aline Papaxanthos (A)

Department of Obstetrics, Gynecology and Reproductive Medicine, Bordeaux University Hospital, Bordeaux, France.

Béatrice Dorphin (B)

AMP74, CH Alpes Léman, Contamine-sur-Arve, France.

Bernard Foliguet (B)

Toxicology and Molecular Biology, Institute Jean Lamour UMR 7198 du CNRS, Université de Lorraine, 54000, Nancy, France.

Chema Triki (C)

Centre d'AMP, Clinique Hannibal, Les Berges du Lac, 1053, Tunis, Tunisia.

Christophe Sifer (C)

Service de Biologie de la Reproduction, d'Histo-Embryologie et Cytogénétique, Hôpital Jean-Verdier, Avenue du 14 Juillet, 93140, Bondy, France.

Dominique Lauton (D)

Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France.

Gérard Tachdjian (G)

UMR 967, INSERM, Service d'Histologie Embryologie et Cytogénétique, Hôpitaux Universitaires Paris-Sud, AP-HP, Clamart, France.

Gilles Schuler (G)

Gynécologie Obstétrique, Sallanches, France.

Hervé Lejeune (H)

Reproductive Medicine Department, Hospices Civils de Lyon, Lyon, France.

Jacques Puechberty (J)

Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Université Montpelier, Montpellier, France.

Julien Bessonnat (J)

CHU de Grenoble, UF de Biologie de la Procréation, 38000, Grenoble, France.

Laurent Pasquier (L)

Service de Génétique Clinique, CLAD Ouest, CHU Rennes, Rennes, France.

Lionel Mery (L)

Service de Médecine de la Reproduction, CHU de Saint-Étienne, Hôpital Nord, 42055, Saint-Étienne Cedex 2, France.

Marine Poulain (M)

Department of Obstetrics and Gynecology, Hôpital Foch, Université de Paris Ouest (UVSQ), Suresnes, France.

Myriam Chaabouni (M)

Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.

Nathalie Sermondade (N)

Service de Biologie de la Reproduction-CECOS, Hôpital Tenon, AP-HP, 75020, Paris, France.

Rosalie Cabry (R)

Department of Obstetrics, Gynaecology and Reproductive Medicine, Picardie University Jules Verne, Amiens University Medical Centre, Amiens, France.

Sebti Benbouhadja (S)

Reproduction Sciences and Surgery Clinique, Ibn Rochd, Constantine, Algeria.

Ségolène Veau (S)

CHU, Centre d'AMP-CECOS, University Rennes, 16 Boulevard de Bulgarie, 35000, Rennes, France.

Cynthia Frapsauce (C)

CHU Bretonneau, Médecine et Biologie de la Reproduction-CECOS, Tours, France.

Valérie Mitchell (V)

EA 4308, Department of Reproductive Biology and Spermiology-CECOS Lille, University Medical Center, 59037, Lille, France.

Vincent Achard (V)

CECOS-Laboratoire de Biologie de la Reproduction, Pôle de Gynécologie Obstétrique et Reproduction (Gynépôle), Assistance Publique-Hôpitaux de Marseille (AP-HM) la Conception, 13005, Marseille, France.
Centre Clinico-Biologique d'Assistance Médicale à la Procréation, Pôle de Gynécologie Obstétrique et Reproduction (Gynépôle), Assistance Publique-Hôpitaux de Marseille (AP-HM) la Conception, 13005, Marseille, France.
Faculté de Médecine, Institut Méditerranéen de Biodiversité et d'Écologie (IMBE UMR 7263), Equipe Biogénotoxicologie, Santé Humaine et Environnement, Aix Marseille Université, CNRS, IRD, Université Avignon, 27, Boulevard Jean-Moulin, 13385, Marseille Cedex 5, France.

Veronique Satre (V)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM de Génétique Chromosomique, 38000, Grenoble, France.

Sylviane Hennebicq (S)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU de Grenoble, UF de Biologie de la Procréation, 38000, Grenoble, France.

Raoudha Zouari (R)

Pôle Femmes-Parents-Enfants, Centre Clinico-Biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Assistance-Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.

Christophe Arnoult (C)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.

Zine-Eddine Kherraf (ZE)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.

Charles Coutton (C)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM de Génétique Chromosomique, 38000, Grenoble, France.

Pierre F Ray (PF)

Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France. pray@chu-grenoble.fr.
CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France. pray@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH